Skip to main content
Top

Drugs & Aging

Issue 7/2013

Content (9 Articles)

Review Article

The Pharmacological Approach to the Elderly COPD Patient

Timothy E. Albertson, Michael Schivo, Amir A. Zeki, Samuel Louie, Mark E. Sutter, Mark Avdalovic, Andrew L. Chan

Review Article

Therapeutic Management of Primary Immunodeficiency in Older Patients

Nisha Verma, Anthony Thaventhiran, Benjamin Gathmann, James Thaventhiran, Bodo Grimbacher

Systematic Review

Sulfonylureas and Risk of Falls and Fractures: A Systematic Review

Kate L. Lapane, Shibing Yang, Monique J. Brown, Rachel Jawahar, Caleb Pagliasotti, Swapnil Rajpathak

Open Access Original Research Article

Combined Olmesartan, Amlodipine, and Hydrochlorothiazide Therapy in Randomized Patients with Hypertension: A Subgroup Analysis of the TRINITY Study by Age

Andrew J. Lewin, Joseph L. Izzo Jr, Michael Melino, James Lee, Victor Fernandez, Reinilde Heyrman

Original Research Article

Polypharmacy and Potentially Inappropriate Medication in the Adult, Community-Dwelling Population in Switzerland

Eva Blozik, Roland Rapold, Jan von Overbeck, Oliver Reich

Original Research Article

Patterns and Determinants of Dementia Pharmacotherapy in a Population-Based Cohort of Home Care Clients

Colleen J. Maxwell, Mary Vu, David B. Hogan, Scott B. Patten, Micaela Jantzi, Marie-Jeanne Kergoat, Nathalie Jetté, Susan E. Bronskill, George Heckman, John P. Hirdes

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine